Global Erectile Dysfunction Drugs Market 2014-2018 is the latest addition to Sandlerresearch.org industry research reports collection. The report is about 26 lists of exhibits and 77 pages published in Sep-2014. Global Erectile Dysfunction Drugs Market 2014-2018 has been prepared based on an in-depth market analysis with inputs from industry experts.

Complete report available @ http://www.sandlerresearch.org/global-erectile-dysfunction-drugs-market-2014-2018.html

Analysts forecast the Global Erectile Dysfunction Drugs market to decline at a CAGR of 4.47% over the period 2013-2018. According to the report, one of the main drivers in the market is the increase in aging population. The number of patients suffering from erectile dysfunction is growing owing to increasing aging population both in developing and developed countries.

Get 20% Discount on this report till May 22, 2015

A man’s failure to sustain an erection that is adequate enough for sexual activity is known as erectile dysfunction. It also refers to the inconsistency to do so, or the inability to endure it for an extended period. Erectile dysfunction can be due to a number of reasons including aging, high blood pressure, diabetes mellitus, depression, smoking, nerve or spinal cord damage, alcoholism, and low testosterone levels. Treatments for erectile dysfunction include adopting a healthy lifestyle, oral phosphodiesterase type 5 (PDE5) inhibitors, vacuum devices, and surgery. Erectile dysfunction affects the quality of life and leads to stress, anxiety, and self-confidence problems. New research is undergoing in the field of erectile dysfunction to find more enhanced and effective therapies.

One of the emerging trends in this market is an increase in awareness of erectile dysfunction. The acceptability of erectile dysfunction drugs is expected to increase owing to increasing public awareness about erectile dysfunction and the need to treat it

Key players in the Global Erectile Dysfunction Drugs Market: Apricus Biosciences Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Eli Lily & Co., Pfizer Inc. and Vivus Inc.

Other Prominent Vendors in the market are: Auxillium Pharmaceuticals, Cristalia Produtos Quimicos Farmaceuticos, Futura Medical, Johnson & Johnson, Meda Pharmaceuticals, Pacific Therapeutics and Seattle Genetics.

Purchase a Copy of the Report @ http://www.sandlerresearch.org/purchase?rname=23077 Get 20% Discount on this report till May 22, 2015 Inquire for Discount @ http://www.sandlerresearch.org/discount?rname=23077

Further, the report states that one of the main challenges in the market is the high cost of erectile dysfunction drugs. Despite numerous benefits, the high cost of erectile dysfunction drugs hinders acceptability among patients. Many patients do not have the required budget for investing in high-cost treatment options.

Key Market Driver - Increase in Aging Population

Key Market Challenge - High Cost

Key Market Trend – Increased Awareness of Erectile Dysfunction

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Erectile Dysfunction Drugs market for the period 2014-2018. The Global Erectile Dysfunction Drugs market can be divided into six segments: PDE 5 Inhibitors, Vacuum Constriction Device, Penile Prosthesis, Vascular Reconstructive Surgery, Injection Therapies, and Testosterone Replacement Therapy. To calculate the market size, the report considers the revenue generated from the sales of various drugs and topical creams used for the treatment of erectile dysfunction.

Global Erectile Dysfunction Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Erectile Dysfunction Drugs market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Inquire for more information @ http://www.sandlerresearch.org/inquire-before-buying?rname=23077

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Erectile Dysfunction Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Erectile Dysfunction Drugs Market Segmentation by Treatment
Exhibit 4: Pfizer's Viagra Revenue 2010-2013 (US$ million)
Exhibit 5: Eli Lily's Cialis Revenue 2010-2013 (US$ million)
Exhibit 6: Bayer's Levitra Revenue 2010-2013 (US$ million)
Exhibit 7: Sales of Top 3 Erectile Dysfunction Drugs FY 2010-2013 (US$ million)
Exhibit 8: Sales of Top 3 Erectile Dysfunction Drugs FY 20010-2013 (US$ million)
Exhibit 9: Global Erectile Dysfunction Drugs Market by Geographical Segmentation 2013
Exhibit 11: Apricus Biosciences: Geographical Segmentation by Revenue 2013
Exhibit 12: Business Segmentation of Bayer AG 2013
Exhibit 13: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)
Exhibit 14: Sales Segmentation of Bayer AG by Geography 2013
Exhibit 15: Dong-A Socio: Business Segmentation 2013

A discount of 20% on all reports published in 2014 and older. The offer is available only till May 22, 2015

Contact [email protected] / Call +1 888 391 5441 for further information on “Global Erectile Dysfunction Drugs Market 2014-2018” report OR for any other market research and intelligence needs you may have for your business.

NOTE: This Report Is NOT Free Of Charge.